While EV surface molecules like glypican-1 predict pancreatic cancer progression 38, 39 or prostate-specific membrane antigen-positive EVs correlate with breast cancer survival 40, proteins in EVs like β-catenin are less studied due to detection challenges. This evidence concerns the gene FOLH1 and familial pancreatic carcinoma.